Testing force feedback in robotic prostate cancer surgery
Part of Cancer, Kidney & urinary clinical trials.
This trial is looking at whether a new force-feedback feature in the da Vinci robotic system helps surgeons learn and operate more safely when removing the prostate for prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 19 or older.
- You have prostate cancer that has not spread beyond the prostate (stage T1 to T3a).
- You are scheduled to have robotic prostate removal surgery at Samsung Medical Center.
- You are healthy enough for general anesthesia and laparoscopic surgery (ASA class I, II, or III).
- Your erectile function is working well enough to score 12 or higher on a standard questionnaire within the last 6 months.
- You agree to join the study after understanding what it involves.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new imaging technique (PSMA-PET/MRI fused with ultrasound) helps surgeons perform more precise robotic prostate removal in men with prostate cancer that has started to spread outside the gland. It aims to improve cancer control and reduce side effects.
This trial compares two nerve-sparing techniques during robotic prostatectomy to see which better preserves urinary and sexual function while still effectively removing the cancer. It is for men with early-stage, favorable-risk prostate cancer who are good surgical candidates.
This study looks at how your health before surgery affects your erectile function after robot-assisted prostate removal. It aims to help doctors predict and improve recovery of erectile function.
This study tests whether remote robotic surgery is safe and effective for people having robot-assisted operations. It may help expand access to specialized surgical care.
This study looks at a robotic prostate operation that aims to remove only the affected side while keeping the urethra (the tube for urination) to help preserve urinary function. It’s for people with low- to intermediate-risk, one-sided prostate cancer and no spread to lymph nodes, bones, or other organs.
This study collects health information from men who have had robotic surgery for prostate cancer. It aims to learn more about the outcomes of this surgery to help improve future care.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.